We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Innovative Treatment for Venous Reflux Disease

By HospiMedica International staff writers
Posted on 13 Apr 2009
A minimally invasive procedure for patients suffering with symptomatic varicose veins and venous reflux offers advantages over conventional vein stripping surgery.

The VNUS Closure procedure consists of inserting a thin radiofrequency (RF) catheter into the diseased vein through a small incision. More...
The catheter then heats the diseased vein sequentially in 7-cm segments, sealing it from the inside and effectively closing it down; blood returning to the heart then naturally reroutes through healthy veins that contain normal valves. The system includes an integrated cable and a streamlined hub designed for easier use and better ergonomics. The device delivers the RF energy via two bipolar electrodes at the distal tip of the rigid shaft, heating the vein wall and creating the vein wall thickening and occlusion. A micro-thermocouple monitors temperature and provides continuous feedback to the physician. The ablation procedure can be performed either as a primary outpatient procedure or as an adjunct to saphenous vein ablation procedures. The VNUS Closure procedure was developed by VNUS Medical Technologies (San Jose, CA, USA).

"In my view the VNUS Closure procedure is the preferred technique to treat venous reflux because it requires no special modifications to operating areas, is well tolerated by patients, requires minimal postprocedure analgesia and is highly effective at permanently closing the vein," said Ian Franklin, a consultant vascular surgeon from the Imperial College London Charing Cross NHS Hospital (London, United Kingdom), commenting on the announcement by the UK National Health Service (NHS) National Innovation Center that identified the VNUS Closure procedure as a select innovative technology that is bringing benefits to NHS hospitals and patients.

"Our treatment alternative has enabled many NHS Trusts to perform a very common operation virtually pain-free in a simple treatment room in around 30-40 minutes without a general anesthetic or overnight stay," responded Michael Branagan-Harris, UK managing director for VNUS Medical Technologies. "This in turn has enabled hospitals to save money by freeing up expensive resources such as operating theatres, ward beds and staff for more invasive procedures."

Varicose veins are caused by increased pressure in the legs as a result of venous reflux and faulty valves in the leg veins. Left untreated, venous reflux can lead to painful varicose veins, swelling in the lower limbs, and skin problems, such as itching, redness, eczema, and leg ulcers.

Related Links:

VNUS Medical Technologies
Imperial College London Charing Cross NHS Hospital



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.